Christian T Bautista1, Eyako K Wurapa2, Warren B Sateren2, Sara M Morris3, Bruce P Hollingsworth3, Jose L Sanchez4. 1. Faculty of Health and Medicine, Lancaster University, Lancaster, United Kingdom. Electronic address: cbautistat@gmail.com. 2. Walter Reed Army Institute of Research, Silver Spring, Maryland. 3. Faculty of Health and Medicine, Lancaster University, Lancaster, United Kingdom. 4. Armed Forces Health Surveillance Branch, Public Health Division, Defense Health Agency, Silver Spring, Maryland.
Abstract
INTRODUCTION: Bacterial vaginosis (BV) is a common vaginal condition in women of reproductive age, which has been associated with Chlamydia trachomatis and Neisseria gonorrhoeae among commercial sex workers and women attending sexually transmitted infection clinics. Pathogen-specific associations between BV and other sexually transmitted infections among U.S. military women have not been investigated. METHODS: A population-based, nested case-control study was conducted of all incident chlamydia and gonorrhea cases reported to the Defense Medical Surveillance System during 2006-2012. Using a density sampling approach, for each chlamydia or gonorrhea case, 10 age-matched (±1 year) controls were randomly selected from those women who were never diagnosed with these infections. Incidence rate ratios were estimated using conditional logistic regression. Statistical analysis was carried out in December 2015. RESULTS: A total of 37,149 chlamydia cases and 4,987 gonorrhea cases were identified during the study period. Antecedent BV was associated with an increased risk of subsequent chlamydia (adjusted incidence rate ratio=1.51; 95% CI=1.47, 1.55) and gonorrhea (adjusted incidence rate ratio=2.42; 95% CI=2.27, 2.57) infections. For every one additional episode of BV, the risk of acquiring chlamydia and gonorrhea infections increased by 13% and 26%, respectively. A monotonic dose-response relationship was also noted between antecedent BV and subsequent chlamydia and gonorrhea infection. In addition, an effect modification on the additive scale was found between BV and African-American race for gonorrhea, but not for chlamydia. CONCLUSIONS: Among U.S. Army women, antecedent BV is associated with an increased risk of subsequent chlamydia and gonorrhea infection.
INTRODUCTION: Bacterial vaginosis (BV) is a common vaginal condition in women of reproductive age, which has been associated with Chlamydia trachomatis and Neisseria gonorrhoeae among commercial sex workers and women attending sexually transmitted infection clinics. Pathogen-specific associations between BV and other sexually transmitted infections among U.S. military women have not been investigated. METHODS: A population-based, nested case-control study was conducted of all incident chlamydia and gonorrhea cases reported to the Defense Medical Surveillance System during 2006-2012. Using a density sampling approach, for each chlamydia or gonorrhea case, 10 age-matched (±1 year) controls were randomly selected from those women who were never diagnosed with these infections. Incidence rate ratios were estimated using conditional logistic regression. Statistical analysis was carried out in December 2015. RESULTS: A total of 37,149 chlamydia cases and 4,987 gonorrhea cases were identified during the study period. Antecedent BV was associated with an increased risk of subsequent chlamydia (adjusted incidence rate ratio=1.51; 95% CI=1.47, 1.55) and gonorrhea (adjusted incidence rate ratio=2.42; 95% CI=2.27, 2.57) infections. For every one additional episode of BV, the risk of acquiring chlamydia and gonorrhea infections increased by 13% and 26%, respectively. A monotonic dose-response relationship was also noted between antecedent BV and subsequent chlamydia and gonorrhea infection. In addition, an effect modification on the additive scale was found between BV and African-American race for gonorrhea, but not for chlamydia. CONCLUSIONS: Among U.S. Army women, antecedent BV is associated with an increased risk of subsequent chlamydia and gonorrhea infection.
Authors: Heng Choon Cheong; Polly Soo Xi Yap; Chun Wie Chong; Yi Ying Cheok; Chalystha Yie Qin Lee; Grace Min Yi Tan; Sofiah Sulaiman; Jamiyah Hassan; Negar Shafiei Sabet; Chung Yeng Looi; Rishein Gupta; Bernard Arulanandam; Sazaly AbuBakar; Cindy Shuan Ju Teh; Li Yen Chang; Won Fen Wong Journal: PLoS One Date: 2019-11-18 Impact factor: 3.240
Authors: Cynthia Rodríguez-Nava; Karen Cortés-Sarabia; Mariana D Avila-Huerta; Edwin J Ortiz-Riaño; Ana K Estrada-Moreno; Luz Del C Alarcón-Romero; Olga Mata-Ruíz; Yolanda Medina-Flores; Amalia Vences-Velázquez; Eden Morales-Narváez Journal: ACS Pharmacol Transl Sci Date: 2021-01-26
Authors: Nazia Rahman; Khalil G Ghanem; Elizabeth Gilliams; Kathleen R Page; Susan Tuddenham Journal: Sex Transm Infect Date: 2020-10-29 Impact factor: 4.199
Authors: Simon Chengo Masha; Collins Owuor; Joyce Mwongeli Ngoi; Piet Cools; Eduard J Sanders; Mario Vaneechoutte; Tania Crucitti; Etienne P de Villiers Journal: PLoS One Date: 2019-12-12 Impact factor: 3.240